NVGN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Novogen Ltd.'s revenue per share for the six months ended in Dec. 2013 was $0.00. Novogen Ltd.'s revenue per share for the trailing twelve months (TTM) ended in Dec. 2013 was $316.85.
During the past 12 months, the average Revenue Per Share Growth Rate of Novogen Ltd. was 48600.00% per year. During the past 3 years, the average Revenue Per Share Growth Rate was 809.40% per year. During the past 5 years, the average Revenue Per Share Growth Rate was 441.70% per year. During the past 10 years, the average Revenue Per Share Growth Rate was 41.50% per year.
During the past 13 years, Novogen Ltd.'s highest 3-Year average Revenue Per Share Growth Rate was 809.40% per year. The lowest was -51.00% per year. And the median was -11.40% per year.
Revenue per Share is the amount of Revenue per outstanding share of the companys stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Novogen Ltd.'s Revenue Per Share for the fiscal year that ended in Jun. 2013 is calculated as
|Revenue Per Share (A: Jun. 2013 )||=||Revenue (A: Jun. 2013 )||/||Total Shares Outstanding (A: Jun. 2013 )|
Novogen Ltd.'s Revenue Per Share for the quarter that ended in Dec. 2013 is calculated as
|Revenue Per Share (Q: Dec. 2013 )||=||Revenue (Q: Dec. 2013 )||/||Total Shares Outstanding (Q: Dec. 2013 )|
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Novogen Ltd. Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2013 was $316.85 Mil.
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth: Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Novogen Ltd. Annual Data
|per share rev||2.95||3.36||3.45||3.76||3.27||2.30||0.39||0.67||611.23||316.85|
Novogen Ltd. Semi-Annual Data
|per share rev||1.03||1.14||-0.72||0.38||0.26||0.39||0.22||0.16||205.13||0.00|